DBP Stock Quote-Double Bond Pharmaceutical International AB Serbia

  • DBP Stock Quote-Double Bond Pharmaceutical International AB Serbia
  • DBP Stock Quote-Double Bond Pharmaceutical International AB Serbia
  • DBP Stock Quote-Double Bond Pharmaceutical International AB Serbia
  • What happened to double bond pharmaceutical International AB (DBP Akt)?
  • As of last trade, Double Bond Pharmaceutical International AB (publ) (DBP B:AKT) traded at 0.458, 55.25% above the 52 week low of 0.295 set on Nov 28, 2023. Data delayed at least 15 minutes, as of Aug 09 2024 17:00 BST. All markets data located on FT.com is subject to the FT Terms & Conditions
  • What is double bond pharmaceutical International AB?
  • Double Bond Pharmaceutical International AB (publ), a pharmaceutical company, engages in the development and commercialization of approaches for the treatment of oncological, infectious, autoimmune, and other life-threatening diseases. It offers Temodex, a therapy to treat malignant brain tumors; and SA033, a therapy to treat cancers in liver.
  • What currency does double bond pharmaceutical International AB (publ) use?
  • Currency figures normalised to Double Bond Pharmaceutical International AB (publ)'s reporting currency: Swedish Krona SEK Double Bond Pharmaceutical International AB (publ) (DBP B:AKT) company profile with history, revenue, mergers & acquisitions, peer analysis, institutional shareholders and more.

Recommended hot-selling products